BOXED WARNING Addiction, abuse, and misuse; life-threatening respiratory depression; risks from concomitant benzodiazepine/other CNS depressant use; neonatal opioid withdrawal syndrome with prolonged use in pregnancy.
FDA dosing
Population
Start
Target
Max
Analgesia / anesthesia adjunct (IV)
Adults
1-2 mcg/kg IV
individualized
Labor and delivery (epidural)
Adults
10-15 mcg with 10 mL bupivacaine 0.125% ± epinephrine
Renal Undefined
Hepatic Undefined
Instructions
Administer only by persons trained in IV/epidural anesthetics and management of respiratory effects of potent opioids.
Ensure opioid reversal agent (naloxone/nalmefene), resuscitation/intubation equipment, and oxygen are readily available.
Use a tuberculin syringe for accurate small-volume dosing.